Clinical development
- Moderna begins pivotal norovirus vaccine trial
30 Sep, 2024 - Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis
30 Sep, 2024 - Ziresovir Reduces Bronchiolitis in Infants Hospitalized With RSV
27 Sep, 2024 - POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP
27 Sep, 2024 - Anti-Fentanyl vaccine one step closer to providing hope
27 Sep, 2024 - How Low Trust in Government May Hurt Clinical Trial Participation
26 Sep, 2024 - RSV Vaccinations During Pregnancy: Improving Infant Outcomes
26 Sep, 2024 - As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech
25 Sep, 2024 - Anixa announces plans to launch Phase II breast cancer vaccine trial
25 Sep, 2024 - Scancell Holdings Reports Promising Vaccine Trials
24 Sep, 2024 - Correcting the Lack of Diversity in Clinical Trials With Community-Based Studies
23 Sep, 2024
0 Comments